Abbott Laboratories reports third-quarter 2026 results before the market opens on October 21, 2026. Abbott Laboratories sells medical devices, diagnostic tests, nutrition products, and medicines. Adjusted earnings are $1.42 per share, matching estimates. Revenue is $13.01 billion, slightly above the $12.99 billion estimate. Abbott reports sales growth of 14.5% and comparable sales growth of 7.0%. Comparable sales growth includes Exact Sciences, which Abbott acquired on March 23, 2026. Under standard account ...

Abbott lowers 2026 sales growth forecast on medical device weakness ...

Vi e w p o i n t | 27 Sep 2026 17:12:49 ET │ 12 pages China Economics US-China Summit Preserves Stability Amid Practical Deliverables CITI'S TAKE The US-China summit in Washington (Sep 23–25) delivered on optics, reaffirming "strategic stability" and mutual intent for leaders' attendance at APEC in Shenzhen (Nov 18–19) and the G20 in Miami (Dec 14–15). Should that materialize, 2026 would see an unprecedented four Trump-Xi meetings, helping lower near-term risk of any breakdown in relations. As expected, the ...